A descriptive evaluation of warfarin use in patients receiving hospice or palliative care services

Journal of Thrombosis and Thrombolysis

Volumn 27, Issue 3, 2009, Pages 334-339

  Hill, Robin R ^a   Martinez, Kerri D ^a   Delate, Thomas ^a   Witt, Daniel M ^a  

^a Kaiser Permanente ^*  (United States)

Author keywords

Anticoagulation; Hospices; Palliative care; Thromboses

Indexed keywords

WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; DRUG FATALITY; DRUG INDICATION; ELDERLY CARE; FEMALE; HEALTH SERVICE; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HOSPICE CARE; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION; VALVULAR HEART DISEASE; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; DRUG EVALUATION; FEMALE; HOSPICES; HUMANS; INTERNATIONAL NORMALIZED RATIO; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PALLIATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WARFARIN;

EID: 64749089390     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-008-0210-5     Document Type: Article

References (15)

1. NHCPO's facts and figures - 2005 findings. Alexandria, VA: National Hospice and Palliative Care Organization, 2006 (Accessed August 13, 2007, at http://nhpco.org/files/public/2005-facts-and-figures.pdf)
2. Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:338S-400S
3. Johnson MJ, Sproule MW, Paul J (1999) The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer. Clin Oncol 11:105-10
4. Büller HR, Agnelli G, Hull RD et al (2004) Antithrombotic therapy for venous thromboembolic disease: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:401S-428S
5. Hull R, Pineo GF, Mah A et al (2002) A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by warfarin sodium [abstract]. Blood 100,148a
6. Hull R, Pineo GF, Mah A et al (2001) Safety and efficacy results for a study investigating the long-term out-of-hospital treatment of patients with proximal-vein thrombosis using subcutaneous low-molecular-weight heparin versus warfarin [abstract]. Thromb Haemost(suppl)abstract OC1647
7. Bristol-Meyers Squibb Company. "Prescribing Information for Coumadin (warfarin)." August 2007 (Accessed September 20, 2007 at http://www.bms.com/cgi-bin/anybin.pl?sql= select%20PPI%20from%20TB_PRODUCT_PPI%20where%20PPI_SEQ=91&key=PPI)
8. Singer DE, Albers GW, Dalen JE et al (2004) Antithrombotic therapy in atrial fibrillation. Chest 126:426S-456S
9. Johnson MJ (1997) Problems of anticoagulation within a palliative care setting: An audit of hospice patients taking warfarin. Palliative Med 11:306-312
10. Noble SIR, Finlay IG (2005) Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? a qualitative study. Palliative Med 19:197-201
11. Bergstralh EJ, Kosanke JL (1995). Computerized matching of controls. Section of Biostatistics Technical Report 56. Mayo Foundation
12. Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-245
13. Ansell J, Hirsh J, Poller L et al (2004) The pharmacology and management of the vitamin K antagonists. Chest 126:204S-233S
14. Lee AY, Levine MN, Baker RI et al (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349:146-153
15. Noble SI, Hood K, Finlay IG (2007) The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: A case series of sixty two patients. Palliative Med 21:473-476